Anshi Pharmaceutical (Zhongshan) Inc, founded in 2003, is a pharmaceutical enterprise integrates production with scientific research & development and marketing. It is a joint venture mostly invested by A&Z Pharmaceutical Inc, National Healthy Science and Technology Industrial Base Development Co Ltd, Pearl Ocean Pharmaceutical Holdings Ltd, etc.
The first phase construction of Anshi Pharmaceutical boasts modern plants covering an area of nearly 13,000 m2, including an OSDF (oral solid dosage form) plant, an OSDF plant (pilot testing), a lyophilized powder injection plant and a softgel manufacturing plant.
We design our premises and purchase our manufacturing facilities and quality testing equipments in strict accordance with FDA cGMP regulations and standards.
In 2005, our OSDF plant and lyophilized powder injection plant successively passed China’s GMP site inspection; in 2008, the softgel plant passed health food GMP certification.
In 2010, Anshi Pharmaceutical passed FDA site inspection, being qualified to export prescription drugs to USA. Previously, however, there are only three or four domestic pharmaceutical enterprises that have passed FDA inspection.
Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Categories affiliated with A&Z Pharmaceutical Inc
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation